Remodeling of cardiomyocyte ion channels in human atrial fibrillation

Basic Research in Cardiology

Volumn 98, Issue 3, 2003, Pages 137-148

  Dobrev, Dobromir ^a   Ravens, Ursula ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atrial fibrillation; Ion channels; Molecular mechanisms

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FLECAINIDE; GAP JUNCTION PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; ION CHANNEL; MESSENGER RNA; NIFEDIPINE; POTASSIUM ION; PROTEIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; SODIUM ION;

ADAPTATION; AMPLITUDE MODULATION; CATHETER ABLATION; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG TARGETING; ELECTRICAL POTENTIAL PARAMETERS; EXPERIMENTAL MODEL; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HUMAN; MOLECULAR MECHANICS; NONHUMAN; POTASSIUM CURRENT; REVIEW; SLOW INWARD CURRENT;

EID: 0038407392     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-003-0409-8     Document Type: Review

References (100)

1. Aime-Sempe C, Folliguet T, Rucker-Martin C, Krajewska M, Krajewska S, Heimburger M, Aubier M, Mercadier JJ, Reed JC, Hatem SN (1999) Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 34: 1577-1586
2. Allessie MA, Bonke FI, Schopman FJ (1977) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 41: 9-18
3. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103: 769-777
4. Allessie MA, Lammers WJ, Bonke IM, Hollen J (1984) Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation 70: 123-135
5. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54: 230-246
6. Allessie R, Nusynowitz M, Abildskov JA, Moe GK (1958) Non-uniform distribution of vagal effects on atrial refractory period. Am J Physiol 194: 406-410
7. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P (1982) Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability. Int J Cardiol 2: 179-197
8. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M (1997) Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96: 3157-3163
9. Ausma J, Coumans WA, Duimel H, Vander Vusse GJ, Allessie MA, Borgers M (2000) Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 47:788-796
10. Ausma J, Duytschaever M, Wijffels M, Borgers M, Allessie M (2001) Loss of efficacy of cardioversion by class Ic drugs after long term atrial fibrillation in the goat. Eur Heart J 21: 53 (Abstract)
11. Bennett MA, Pentecost BL (1970) The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation 96: 981-988
12. to in rapid atrial pacing in rabbits. J Am Coll Cardiol 41:858-869
13. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kühlkamp V (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44: 121-131
14. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P (1986) Inhomogeneity of cellular refractoriness in human atrium: Factor of arrhythmia? Pacing Clin Electrophysiol 9: 1095-1100
15. + current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J Mol Cell Cardiol 32: 1885-1896
16. Brundel BJ, Ausma J, Van Gelder IC, Vander Want JJ, Van Gilst WH, Crijns HJ, Henning RH (2002) Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 54: 380-389
17. Brundel BJJM, Van Gelder IC, Henning RJ, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Grijns JGM (2001) Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103: 684-690
18. Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, Van Gilst WH, Crijns HJ (1999) Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 42: 443-454
19. + channels. J Am Coll Cardiol 37: 926-932
20. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR (2001) Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89: E32-E38
21. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA, Chang MS (1998) Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol 32: 732-738
22. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radio-frequency ablation. Circulation 100: 1879-1886
23. Coumel P (1996) Role of the autonomic nervous system in paroxysmal atrial fibrillation. In: Touboul PC, Waldo AL (eds) Atrial Flutter. Amonk, NY: Futura Publishing Co, pp 248-261
24. Crijns HJ, Van Wijk LM, Van Gilst WH, Kingma JH, Van Gelder IC, Lie KI (1999) Acute conversion of atrial fibrillation to sinus rhythm: Clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 9: 634-638
25. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G (1998) The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 79: 129-168
26. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F (1996) Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 94: 1600-1606
27. Dhein S (1998) Cardiac Gap Junctions. Physiology, Regulation, Pathophysiology and Pharmacology. Basel, Switzerland, Karger
28. K,ACh and muscarinic receptor-mediated shortening of action potentials. Circulation 104: 2551-2557
29. Dobrev D, Wettwer E, Kortner A, Knaut M, Schüler S, Ravens U (2002) Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 54: 397-404
30. DuPont E, Ko Y, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ (2001) The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 103: 842-849
31. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST investigators (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. New Engl J Med 324: 781-788
32. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M (1997) Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 30: 1785-1792
33. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maeri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96: 1180-1186
34. Fynn SP, Todd DM, Hobbs WJ, Armstrong KL, Garratt CJ (2001) Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; A manifestation of atrial electrical remodeling in humans? Eur Heart J 22: 1822-1834
35. Glitsch HG (2001) Electrophysiology of the sodium-potassium-ATPase in cardiac cells. Physiol Rev 81: 1791-1826
36. Goette A, Honeycutt C, Langberg JJ (1996) Electrical remodeling in atrial fibrillation: Time course and mechanisms. Circulation 94: 2968-2974
37. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U (2000) Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35: 1669-1677
38. Goette A, Arndt M, Rocken C, Spiess A, Staack T, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U (2000) Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101: 2678-2681
39. Goette A, Arndt M, Rocken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U (2002) Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283: H264-H272
40. Gonzalez RA, Campos EO, Karmelic C, Moran S, Inestrosa NC (1993) Acetylcholinesterase changes in hearts with SR and atrial fibrillation. Gen Pharmacol 24: 111-114
41. 2+ channel in persistent atrial fibrillation in humans. Z Kardiol 89: 23-29
42. Grammer JB, Bosch RF, Kühlkamp V, Seipel L (2000) Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol 11: 626-633
43. 2+-channel, β-adrenoceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res Cardiol 96: 82-90
44. Haissaguerrei M, Jais P, Shah DC, Takahashi A, Hocini M, Queniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339: 659-666
45. Hocini M, Ho SY, Kawara T, Linenbank AC, Potse M, Shah D, Jais P, Janse MJ, Haissaguerre M, De Bakker JM (2002) Electrical conduction in canine pulmonary veins: Electrophysiological and anatomic correlation. Circulation 105: 2442-2448
46. f) by antiarrhythmic agents in isolated human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol 358: 635-640
47. + channel in guinea-pig cardiac myocytes. J Physiol (London) 510: 755-771
48. Kamalvand K, Tan K, Lloyd G, Gill J, Bucknall C, Sulke N (1999) Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man. Eur Heart J 20: 888-895
49. Kim BS, Kim YH, Hwang GS, Pak HN, Lee SC, Shim WJ, Oh DJ, Ro YM (2002) Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol 39: 1329-1336
50. 2+-handling by atrial tachycardia: Evidence for a role in loss of rate-adaptation. Cardiovasc Res 54: 416-426
51. Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel S (2002) Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties. Circ Res 90: E73-E87
52. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54: 361-379
53. K,ACh in atrial fibrillation using a mouse knock-out model. J Am Coll Cardiol 37: 2136-2143
54. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban. J Am Coll Cardiol 33: 1231-1237
55. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS, Tseng YZ, Lien WP, Huang SK (1999) Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation. Cardiology 92: 248-255
56. f channel mRNA in human atrial tissue: Correlation with left atrial filling pressure and atrial fibrillation. J Cardiovasc Electrophysiol 10: 947-953
57. Liu L, Nattel S (1997) Differing sympathetic and vagal effects on atrial fibrillation in dogs: Role of refractioness heterogeneity. Am J Physiol 273: H805-H816
58. Miake J, Marban E, Nuss HB (2002) Gene therapy: Biological pacemaker created by gene transfer. Nature (London) 419: 132-133
59. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA (2001) Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104: 174-180
60. Nattel S (1999) Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 42: 298-308
61. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature (London) 415: 219-226
62. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, De Vivie ER, Dhein S (2001) Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38: 883-891
63. Prystowsky EN, Naccarelli GV, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP (1983) Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 51: 96-100
64. Ravens U, Dobrev D (2003) Cardiac sympathetic innervation and control of potassium channel function. J Moll Cell Cardiol 35: 137-139
65. Rensma PL, Allessie MA, Lammers WJ, Bonke FI, Schalij MJ (1988) Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 62: 395-410
66. Samie FH, Berenfeld O, Anumonwo J, Mironov SF, Udassi S, Beaumont J, Taffet S, Pertsov AM, Jalife J (2001) Rectification of the background potassium current: A determinant of rotor dynamics in ventricular fibrillation. Circ Res 89: 1216-1223
67. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM (2000) Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 102: 2774-2780
68. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D, Schoendube F, Hanrath P, Allessie MA (2001) Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103: 691-698
69. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C, Vazquez-Jimenez JF, Schoendube F, Hanrath P, Allessie M (2002) Atrial fibrillation-induced atrial contractile dysfunction: A tachycardiomyopathy of a different sort. Cardiovasc Res 53: 192-201
70. 2+ channel subunits is not reduced in atrial myocardium of patients with atrial fibrillation. Pacing Clin Electrophysiol 23: 604 (Abstract)
71. Shi Y, Li D, Tardif JC, Nattel S (2002) Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 54: 456-461
72. 2+ exchange. Molecular and pharmacological aspects. Circ Res 88: 864-876
73. Skasa M, Jüngling E, Picht E, Schöndube F, Lückhoff A (2001) L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol 96: 151-159
74. Sorimachi H, Ishiura S, Suzuki K (1997) Structure and physiological function of calpains. Biochem J 328; 721-732
75. Sparks PB, Jayaprakash S, Vohra JK, Kalman JM (2000) Electrical remodeling of the atria associated with paroxysmal and chronic atrial flutter. Circulation 102: 1807-1813
76. Sueda S, Fukuda H, Watanabe K, Ochi N, Kawada H, Hayashi Y, Uraoka T (2001) Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine. Am J Cardiol 88: 570-573
77. Sun H, Chartier D, Leblanc N, Nattel S (2001) Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49: 751-761
78. The Sicilian gambit (1991) A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation 84: 1831-1851
79. Thijssen VL, Ausma J, Liu GS, Allessie MA, Van Eys GJ, Borgers M (2000) Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 9: 17-28
80. Tieleman RG, Crijns HJ (2000) The 'second factor' of tachycardia-induced atrial remodeling. Cardiovasc Res 46: 364-366
81. Van Gelder IC, Brundel BJ, Henning RH, Tuinenburg AE, Tieleman RG, Deelman L, Grandjean JG, De Kam PJ, Van Gilst WH, Crijns HJ (1999) Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 10: 552-560
82. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI (1991) Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68: 41-46
83. Van Wagoner DR, Nerbonne JM (2000) Molecular basis of electrical remodeling in atrial fibrillation. J Mol Cell Cardiol 32: 1101-1117
84. 2+ currents and human atrial fibrillation. Circ Res 85: 428-426
85. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80: 772-781
86. Vitadello M, Ausma J, Borgers M, Gambino A, Casarotto DC, Gorza L (2001) Increased myocardial GRP94 amounts during sustained atrial fibrillation: A protective response? Circulation 103: 2201-2206
87. White CW, Kerber RE, Weiss HR, Marcus ML (1982) The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res 51: 205-215
88. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake, chronically instrumented conscious goats. Circulation 92: 1954-1968
89. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Power J, Allessie MA (1997) Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96: 3710-3720
90. Wijffels MC, Dorland R, Mast F, Allessie MA (2000) Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 102: 260-267
91. Workman AJ, Kane KA, Rankin AC (2001) The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 52: 226-235
92. Wouters L, Liu GS, Flameng W, Thijssen VL, Thone F, Borgers M (2001) Structural remodeling of atrial myocardium in patients with cardiac valve disease and atrial fibrillation. Exp Clin Cardiol 5: 158-163
93. Yamada M, Inanobe A, Kurachi Y (1998) G protein regulation of potassium ion channels. Pharmacol Rev 50: 723-757
94. + channels in rat atrium. Circulation 101: 2007-2014
95. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81: 512-525
96. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S (1999) Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 84: 776-784
97. Yu W, Lee S, Tai C, Tsai C, Hsieh M, Chen C, Ding Y, Chang M, Chen S (1999) Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 42: 470-476
98. K1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol (London) 533.3:697-710
99. Zhuang S, Zhang Y, Mowrey KA, Li J, Tabata T, Wallick DW, Popovic ZB, Grimm RA, Natale A, Mazgalev TN (2002) Ventricular rate control by selective vagal stimulation is superior to rhythm regularization by atrioventricular nodal ablation and pacing during atrial fibrillation. Circulation 106: 1853-1858
100. Zipes DP (1997) The seventh annual Gordon K. Moe Lecture. Atrial fibrillation: From cell to bedside. J Cardiovasc Electrophysiol 8: 927-938